KR102705675B1 - 수지제 용기에 충전된 은염 함유 안과용 수성 조성물 - Google Patents

수지제 용기에 충전된 은염 함유 안과용 수성 조성물 Download PDF

Info

Publication number
KR102705675B1
KR102705675B1 KR1020227037013A KR20227037013A KR102705675B1 KR 102705675 B1 KR102705675 B1 KR 102705675B1 KR 1020227037013 A KR1020227037013 A KR 1020227037013A KR 20227037013 A KR20227037013 A KR 20227037013A KR 102705675 B1 KR102705675 B1 KR 102705675B1
Authority
KR
South Korea
Prior art keywords
aqueous composition
ophthalmic aqueous
silver nitrate
ophthalmic
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020227037013A
Other languages
English (en)
Korean (ko)
Other versions
KR20220161379A (ko
Inventor
유스케 모모카와
마키 이이다
히로유키 아사다
도요미 후지사와
Original Assignee
산텐 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산텐 세이야꾸 가부시키가이샤 filed Critical 산텐 세이야꾸 가부시키가이샤
Priority to KR1020247029902A priority Critical patent/KR20240135080A/ko
Publication of KR20220161379A publication Critical patent/KR20220161379A/ko
Application granted granted Critical
Publication of KR102705675B1 publication Critical patent/KR102705675B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Bridges Or Land Bridges (AREA)
KR1020227037013A 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물 Active KR102705675B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020247029902A KR20240135080A (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2020-062252 2020-03-31
JP2020062252 2020-03-31
PCT/JP2021/007366 WO2021199814A1 (ja) 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020247029902A Division KR20240135080A (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Publications (2)

Publication Number Publication Date
KR20220161379A KR20220161379A (ko) 2022-12-06
KR102705675B1 true KR102705675B1 (ko) 2024-09-11

Family

ID=77930318

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020227037013A Active KR102705675B1 (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물
KR1020247029902A Pending KR20240135080A (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020247029902A Pending KR20240135080A (ko) 2020-03-31 2021-02-26 수지제 용기에 충전된 은염 함유 안과용 수성 조성물

Country Status (8)

Country Link
US (1) US20230145529A1 (enExample)
EP (1) EP4129341A4 (enExample)
JP (4) JP7053966B2 (enExample)
KR (2) KR102705675B1 (enExample)
CN (1) CN115348871B (enExample)
CA (1) CA3176584A1 (enExample)
TW (1) TWI896607B (enExample)
WO (1) WO2021199814A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005162648A (ja) * 2003-12-01 2005-06-23 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
KR100557679B1 (ko) * 2004-01-07 2006-03-07 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
JP4856392B2 (ja) 2004-04-23 2012-01-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
IN2014MN01555A (enExample) * 2012-02-27 2015-07-03 Rohto Pharma
KR20150119303A (ko) * 2013-02-15 2015-10-23 센주 세이야꾸 가부시키가이샤 항균성 금속을 함유하는 디플루프레드네이트 유액 조성물
US20160022648A1 (en) * 2013-03-13 2016-01-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for meibomian gland dysfunction
SG11201705138QA (en) * 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution
JP6611444B2 (ja) * 2015-03-24 2019-11-27 ロート製薬株式会社 眼科用組成物
TWI711453B (zh) 2015-06-05 2020-12-01 日商參天製藥股份有限公司 抑制水性點眼液中之洛赫西定類的殘存率降低之方法
JP6615548B2 (ja) * 2015-08-06 2019-12-04 ロート製薬株式会社 眼科組成物
JP7317714B2 (ja) * 2017-12-01 2023-07-31 参天製薬株式会社 眼科用製品
US11602561B2 (en) * 2018-06-28 2023-03-14 Csp Advanced Solutions Inc. Treatment method and system for epidemic keratoconjunctivitis
JP7139206B2 (ja) 2018-09-21 2022-09-20 小林製薬株式会社 医薬組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005162648A (ja) * 2003-12-01 2005-06-23 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物

Also Published As

Publication number Publication date
CN115348871A (zh) 2022-11-15
CA3176584A1 (en) 2021-10-07
JP2025146955A (ja) 2025-10-03
US20230145529A1 (en) 2023-05-11
KR20220161379A (ko) 2022-12-06
WO2021199814A1 (ja) 2021-10-07
JP7169477B2 (ja) 2022-11-10
JP2023001184A (ja) 2023-01-04
JPWO2021199814A1 (enExample) 2021-10-07
JP2022087168A (ja) 2022-06-09
EP4129341A4 (en) 2024-04-24
JP7053966B2 (ja) 2022-04-12
JP7721498B2 (ja) 2025-08-12
EP4129341A1 (en) 2023-02-08
CN115348871B (zh) 2025-08-08
KR20240135080A (ko) 2024-09-10
TW202203920A (zh) 2022-02-01
TWI896607B (zh) 2025-09-11

Similar Documents

Publication Publication Date Title
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
EP3706715B1 (en) Ophthalmic pharmaceutical composition containing a combination of brinzolamide and brimonidine and method of preparation thereof
KR102705675B1 (ko) 수지제 용기에 충전된 은염 함유 안과용 수성 조성물
JP2023093601A (ja) 眼科用製品
US11324829B2 (en) Antiseptic agent comprising meglumine or salt thereof
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
JP7144630B2 (ja) レバミピドまたはその塩および高分子を含有する水性懸濁液
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物
HK1257724A1 (en) Pharmaceutical composition including dorzolamide and brimonidine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20221024

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240220

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20240905

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240906

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240906

End annual number: 3

Start annual number: 1

PG1601 Publication of registration